Classification of diabetes in young adults: New concepts for an old disease

Diabetes and Metabolism

Volumn 31, Issue 6, 2005, Pages 595-598

  Cugnet, C ^a   Thivolet, C ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Classification; Diabetes; Insulin

Indexed keywords

INSULIN; INSULIN GLARGINE; METFORMIN;

ACANTHOSIS NIGRICANS; ADULT; ANAMNESIS; ARTICLE; BODY WEIGHT; CASE REPORT; CELL DENSITY; CLINICAL EXAMINATION; CONCEPT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MATERNALLY INHERITED DIABETES AND DEAFNESS; METABOLIC REGULATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; QUANTITATIVE ANALYSIS; RISK FACTOR;

EID: 29344473759     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70236-7     Document Type: Article

References (26)

1. Diagnosis and classification of diabetes mellitus, ADA, Diabetes Care, 2004: 27:s5-s10
2. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001;44:914-22
3. Bottazo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2:1279-83
4. Yu l, Cuthbertson DD, Maclaren N, et al. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1. Diabetes 2001;50:1735-40
5. Fajans SS, Bell GI, Polonsky KS. Molecular mechanism and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345:971-80
6. Van Den Ouweland JM, Lemkes HHPJ, Trembath RC, et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA gene. Diabetes 1996;45:113-26
7. Gerbitz KD, Gempel K, Brdiczka D. Mitochondria and diabetes: genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 1996;45:113-26
8. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004;47:943-56
9. Rosenbloom A, Joe J, Young R, Winter W. Emerging epidemic of T2D in youth. Diabetes care 1999;22:345-54
10. Savage PJ, Bennett PH, Senter RG, Miller M. High prevalence of diabetes in young Pima Indians. Diabetes 1979;28:937-42
11. Wabitsch M, Hauner H, Hertrampf M, et al. Type 2 diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord 2004;28:307-13
12. Sinha R, Fish G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2004;346:802-10
13. Ten S, MacLaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004;89:2526-39
14. Zimmer P, Collins V, Downe G, Knight L. Hyperinsulinaemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35: 534-41
15. Gabbay M, Cesarini PR, Dib SA. Type 2 diabetes in children and adolescents: literature review. J Pediatr 2003;79:201-8
16. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996;128:608-15
17. Stuart CA, Gilkison R, Smith MM, Bosma AM, Keenan BS, Nagamani M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr 1998;37:73-80
18. De Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents. Circulation 2004; 110:2494-7
19. Drake AJ, Smith A, Betts PR, Crowne EC, Shield JPH. Type 2 diabetes in obese white children. Arch Dis Child 2002;86:207-8
20. Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-saharian african origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 2004;53:645-53
21. Chiasson JL, Rabasa-Lhoret R. Prevention of type 2 diabetes: insulin resistance and beta-cell function. Diabetes 2004;53:s34-s38
22. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346: 393-403
23. Pereira MA, Kartashow AI, Ebbeling CB, et al. Fast-foot habits, weight gain, and insulin resistance (the Cardia study): 15-year prospective analysis. Lancet 2005;365:36-42
24. Tuomilehto J, Lindström J, Eriksson JG. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50
25. Juhl Cb, Hollingdal M, Porksen N, Prange A, Lönngvist F, Schmitz O. Influence of rosiglitazone treatment on ε -cell function in type 2 diabetes: evidence of an increased ability of glucose to entrain high-frequency insulin pulsatility. J Clin Endocrinol Metab 2003;88:3794-800
26. Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. A meta-analysis of randomised clinicals trials. Diabetes Metab 2004;30:487-96